Paul Robert Hartmeier

Title: Paul Robert Hartmeier: Innovator in Pharmaceutical Chemistry

Introduction

Paul Robert Hartmeier is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of Syk inhibitors. With a total of 2 patents, Hartmeier's work is recognized for its innovative approach to drug formulation.

Latest Patents

Hartmeier's latest patents focus on hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitors. These patents detail the polymorphs of a bis-mesylate salt of a compound of Formula IA, including processes for making the polymorphs and methods of use thereof. His research aims to enhance the efficacy and stability of pharmaceutical compounds.

Career Highlights

Currently, Paul Robert Hartmeier is associated with Kronos Bio, Inc., where he continues to push the boundaries of pharmaceutical innovation. His expertise in the field has led to advancements that are crucial for developing new therapeutic options.

Collaborations

Hartmeier collaborates with esteemed colleagues such as Peter Chee-Chu Fung and Jesper Alexis Jernelius. These partnerships foster a dynamic environment for research and development, contributing to the success of their projects.

Conclusion

Paul Robert Hartmeier stands out as a key figure in pharmaceutical innovation, with a focus on Syk inhibitors and polymorphs. His contributions are paving the way for future advancements in drug development.